These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7736694)

  • 1. Circulating antibodies to cardiac protein-acetaldehyde adducts in alcoholic heart muscle disease.
    Harcombe AA; Ramsay L; Kenna JG; Koskinas J; Why HJ; Richardson PJ; Weissberg PL; Alexander GJ
    Clin Sci (Lond); 1995 Mar; 88(3):263-8. PubMed ID: 7736694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis.
    Koskinas J; Kenna JG; Bird GL; Alexander GJ; Williams R
    Gastroenterology; 1992 Dec; 103(6):1860-7. PubMed ID: 1451979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease.
    Rolla R; Vay D; Mottaran E; Parodi M; Traverso N; Aricó S; Sartori M; Bellomo G; Klassen LW; Thiele GM; Tuma DJ; Albano E
    Hepatology; 2000 Apr; 31(4):878-84. PubMed ID: 10733543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen-acetaldehyde adducts in alcoholic and nonalcoholic liver diseases.
    Svegliati-Baroni G; Baraona E; Rosman AS; Lieber CS
    Hepatology; 1994 Jul; 20(1 Pt 1):111-8. PubMed ID: 7912686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IgA antibodies to human gut luminal aspirates and human liver in alcoholic liver disease.
    Douds AC; Lewis DJ; Lim AG; Maxwell JD; Poulton TA
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1383-8. PubMed ID: 9802516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: relationship to liver disease severity and alcohol consumption.
    Viitala K; Israel Y; Blake JE; Niemelä O
    Hepatology; 1997 Jun; 25(6):1418-24. PubMed ID: 9185762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the usefulness of acetaldehyde-modified proteins and associated antibodies as markers of alcohol abuse.
    Worrall S; Jersey JD; Wilce PA; Seppa K; Sillanaukee P
    Alcohol Alcohol Suppl; 1994; 2():503-7. PubMed ID: 8974375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetaldehyde/protein interactions: are they involved in the pathogenesis of alcoholic liver disease?
    Worrall S; de Jersey J; Nicholls R; Wilce P
    Dig Dis; 1993; 11(4-5):265-77. PubMed ID: 8222307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein adduct species in muscle and liver of rats following acute ethanol administration.
    Patel VB; Worrall S; Emery PW; Preedy VR
    Alcohol Alcohol; 2005; 40(6):485-93. PubMed ID: 16131499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune response against protein epitopes modified with acetaldehyde and its clinical significance in alcoholic liver diseases].
    Yokoyama H
    Arukoru Kenkyuto Yakubutsu Ison; 1993 Dec; 28(6):483-96. PubMed ID: 7510476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease.
    Li CJ; Nanji AA; Siakotos AN; Lin RC
    Hepatology; 1997 Sep; 26(3):650-7. PubMed ID: 9303495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-low-density lipoprotein antibodies in alcoholics without and with liver disease and in social drinkers.
    Wehr H; Milewski B; Pozniak M; Rodo M
    Alcohol Alcohol; 1997; 32(1):43-9. PubMed ID: 9131891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and subcellular localization of acetaldehyde-protein adducts in liver biopsies from alcoholic patients.
    Paradis V; Scoazec JY; Köllinger M; Holstege A; Moreau A; Feldmann G; Bedossa P
    J Histochem Cytochem; 1996 Sep; 44(9):1051-7. PubMed ID: 8773571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease.
    Tuma DJ; Klassen LW
    Gastroenterology; 1992 Dec; 103(6):1969-73. PubMed ID: 1451988
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol and the myocardium.
    Richardson PJ; Patel VB; Preedy VR
    Novartis Found Symp; 1998; 216():35-45; discussion 45-50. PubMed ID: 9949786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential contribution of clinical amounts of acetaldehyde to skeletal and cardiac muscle dysfunction in alcoholic myopathy.
    Oba T; Maeno Y; Ishida K
    Curr Pharm Des; 2005; 11(6):791-80. PubMed ID: 15777233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme immune assay for serum anti-acetaldehyde adduct antibody using low-density lipoprotein adduct and its significance in alcoholic liver injury.
    Nagata N; Nishizaki Y; Watanabe N; Tsuda M; Matsuzaki S
    Alcohol Clin Exp Res; 1998 May; 22(S3 Pt 1):150S-155S. PubMed ID: 9622394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against acetaldehyde-modified epitopes: an elevated IgA response in alcoholics.
    Worrall S; de Jersey J; Shanley BC; Wilce PA
    Eur J Clin Invest; 1991 Feb; 21(1):90-5. PubMed ID: 1713848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation in alcoholic myopathy and cardiomyopathy.
    García-Buñuel L
    Med Hypotheses; 1984 Feb; 13(2):217-31. PubMed ID: 6371456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against malondialdehyde-acetaldehyde adducts can help identify patients with abdominal aortic aneurysm.
    Carson JS; Xiong W; Dale M; Yu F; Duryee MJ; Anderson DR; Thiele GM; Baxter BT
    J Vasc Surg; 2016 Feb; 63(2):477-84. PubMed ID: 25724613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.